Compare Ecolab Inc. (ECL) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Neurocrine Biosciences Inc — how do they compare? Ecolab Inc. trades at $285 (market cap $79.79B), while Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B). The key difference: Ecolab Inc. is far larger — about 4.8× Neurocrine Biosciences Inc's market cap, and Ecolab Inc. pays a 1.03% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| ECL | NBIX | |
|---|---|---|
Market Cap | $79.79B | $16.46B |
Sector | Consumer Cyclical | Health |
52-Week High | $308.35 | $185.50 |
52-Week Low | $245.73 | $123.10 |
Enterprise Value | $88.57B | $16.48B |
Dividend Yield | 1.03% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
